COA: CMS Allows Middlemen to Force Patients to “Fail First” While Paradoxically Keeping Cancer a Protected Class

COA

Community Oncology Alliance (COA) logo

Final Part D Rule Means All Medicare Patients with Cancer Will Face a More Dangerous Nightmare of Denials and Delays to Physician-Prescribed Treatments

CMS’ final rule means that oncologists will face more barriers to providing cancer patients with the treatments that they need, when they need them.”

— Michael Diaz, M.D., COA president

WASHINGTON, DISTRICT OF COLUMBIA, UNITED STATES, May 23, 2019 /EINPresswire.com/ — The Centers for Medicare & Medicaid Services (CMS) recently released its final rule for Medicare Part D that will maintain the status of cancer as a “protected class” in Medicare Advantage (MA). The Community Oncology Alliance (COA) commends CMS for this decision; however, and paradoxically, in the final rule, CMS codified its decision to allow MA plans to use “fail first” step therapy for new starts of Part B drugs for cancer and other serious diseases. The Trump administration’s decision to finalize step therapy in MA plans means that Medicare patients with cancer will face nightmares of delays and denials while trying to access their physician-prescribed treatments.

As COA noted in our strong opposition and comments to the original decision on “fail first” step therapy, the Trump administration has perpetuated a nightmare for Medicare patients with cancer. We are already seeing patients facing significantly increased difficulty accessing the evidence-based treatments that trained oncologists have prescribed for their individual cancers. This final rule puts medical decision making in the hands of middlemen – health plans and pharmacy benefit managers (PBMs) – who can force use of older, less-appropriate cancer treatment or drugs simply because of cost.

Step therapy requirements are driven by financial interests to save money and not by what is in the best interest of a patient with cancer. They leave patients at the whim of MA health plans and PBMs that are more concerned with their financial well-being than patient outcomes and side effects. Additionally, far from a focus on saving money, COA has seen several examples where step therapy decisions are made to push the drug that will provide the middlemen the maximum rebate, not necessarily the lower cost. This includes plans preferring expensive brand name drugs where generics or biosimilars are available, all because of secret contracts and formularies that earn the middlemen more in rebates.

Even with the status quo in which cancer remains a protected class, middlemen-dictated restrictions on drug access already cause patients extreme difficulty, which can result in lengthy delays and questionable denials for access to life-saving treatment. Countless times, bureaucratic middlemen delays have meant that patients with cancer must postpone treatment that would give them their best chance at battling this devastating disease. COA has highlighted numerous PBM horror stories in a series of papers, pulled from our extensive and ever-growing database of real stories submitted by practices across the country. Giving MA plans more authority to place hurdles between patients and their prescribed therapies shifts decision making away from the clinical expertise of providers and instead places it with financially motivated corporate middlemen.

Even though CMS proposes patient safeguards, such as an appeals process, it is incomprehensible to require patients receiving cancer treatment, or their already overwhelmed and distressed family members and/or caregivers, to first fail on inferior, sometimes inappropriate cancer therapy, let alone navigate a bureaucratic appeals process. Moreover, allowing broader use of prior authorization and “fail first” step therapy for protected classes, places an additional administrative burden on providers to sort through utilization management processes in order to ensure access to cancer treatment in a timely manner. It is not uncommon for community oncology practices to spend many valuable hours on overcoming PBM and plan sponsor denials of medication needed by critically ill patients.

“Oncologists are challenged every day by our patients who present with complex cancer cases. Each of these require individualized, evidence-based treatment plans that are informed by our years of education, experience, and most importantly, firsthand observations of that particular patient,” said Michael Diaz, M.D., a practicing medical oncologist at Florida Cancer Specialists & Research Institute, and COA president. “CMS’ final rule means that oncologists will face more barriers to providing cancer patients with the treatments that they need, when they need them. At a time when we are trying to improve the health care system, it is unconscionable that the administration would finalize such a dangerous proposal that will only make patient care more difficult and complex.”

“There is only one word for ‘fail first’ step therapy for patients with cancer: inhumane,” said Ted Okon, executive director of COA. “Anyone who has experienced cancer knows that dealing with middlemen who come between them and their treatments is a true nightmare. Worst of all, the dirty little secret is that it isn’t in the best interest of patient care or outcomes – it is all to save middlemen corporations a buck while patients suffer. The administration has made a huge mistake with moving this final rule forward and we implore them to reconsider.”

COA implores the Trump administration to rescind this final rule and reconsider allowing “fail first” step therapy in Medicare. As noted in our original comment letter on this proposed rule, we recommend that treatments prescribed in line with provider-developed clinical guidelines, pathways, or evidence-based protocols should be made available with minimal middleman interference and on the lowest or preferred tiers. This would better align all health care stakeholders and incentivize high-value care.

COA commends and continues to support the Trump administration’s efforts to achieve lower drug prices and reduce cancer care costs for Medicare and beneficiaries. However, this cannot come by putting the health of Medicare seniors with cancer and other serious diseases in jeopardy. Middlemen should not be empowered to make or deny individualized, evidence-based treatment decisions for patients with cancer. The proposed rule will have a tremendous impact on patient outcomes, the physician-patient relationship, and administrative burdens, all of which our government should be seeking to improve, not worsen.

###

The Community Oncology Alliance (COA) is a non-profit organization dedicated solely to preserving and protecting access to community cancer care, where the majority of Americans with cancer are treated. COA leads community cancer clinics in navigating an increasingly challenging environment to provide efficiencies, patient advocacy, and proactive solutions to Congress and policymakers. Learn more about COA at www.CommunityOncology.org.

Nicolas Ferreyros
Community Oncology Alliance
+1 6466854262
email us here
Visit us on social media:
Facebook
Twitter
LinkedIn


Source: EIN Presswire

Global Luxury Massage Chair Market Size, Growth, Analysis, Drivers and Challenges | 2019-2025

Wise.Guy12

Wise.Guy.

Wiseguyreports.Com Adds “Luxury Massage Chair 2019-2025 Global Market Survey Industry Key Players" To Its Research Database

PUNE, MAHARASTRA, INDIA, May 23, 2019 /EINPresswire.com/ — Luxury Massage Chair Market 2019-2025

Description: –

Global Luxury Massage Chair Market Report 2019 – Market Size, Share, Price, Trend and Forecast is a professional and in-depth study on the current state of the global Luxury Massage Chair industry.

Scope of the Report:

1.The report provides key statistics on the market status of the Luxury Massage Chair manufacturers and is a valuable source of guidance and direction for companies and individuals interested in the industry.
2.The report provides a basic overview of the industry including its definition, applications and manufacturing technology.
3.The report presents the company profile, product specifications, capacity, production value, and 2013-2018 market shares for key vendors.
4.The total market is further divided by company, by country, and by application/type for the competitive landscape analysis.
5.The report estimates 2019-2024 market development trends of Luxury Massage Chair industry.
6.Analysis of upstream raw materials, downstream demand, and current market dynamics is also carried out
7.The report makes some important proposals for a new project of Luxury Massage Chair Industry before evaluating its feasibility.

Free Sample Report @ https://www.wiseguyreports.com/sample-request/3973642-global-luxury-massage-chair-market-report-2019-market

The major manufacturers covered in this report

* Panasonic
* Osaki
* Inada
* Human Touch
* Fujiiryoki
* Titan
For complete companies list, please ask for sample pages.

The information for each competitor includes:
* Company Profile
* Main Business Information
* SWOT Analysis
* Sales, Revenue, Price and Gross Margin
* Market Share

For product type segment, this report listed main product type of Luxury Massage Chair market
* Heated Massage Chairs
* Inversion Massage Chairs
* Zero Gravity Massage Chairs
* Targeted Massage Products

For Detailed Report Visit @ https://www.wiseguyreports.com/reports/3973642-global-luxury-massage-chair-market-report-2019-market

Major Key Points in Table of Content:

Chapter 1 Executive Summary

Chapter 2 Abbreviation and Acronyms

Chapter 3 Preface
3.1 Research Scope
3.2 Research Methodology
3.2.1 Primary Sources
3.2.2 Secondary Sources
3.2.3 Assumptions

Chapter 4 Market Landscape
4.1 Market Overview
4.2 Classification/Types
4.3 Application/End Users

Chapter 5 Market Trend Analysis
5.1 Introduction
5.2 Drivers
5.3 Restraints
5.4 Opportunities
5.5 Threats

…………….

Chapter 16 Analysis of Global Key Vendors
16.1 Panasonic
16.1.1 Company Profile
16.1.2 Main Business and Luxury Massage Chair Information
16.1.3 SWOT Analysis of Panasonic
16.1.4 Panasonic Luxury Massage Chair Sales, Revenue, Price and Gross Margin (2014-2019)
16.2 Osaki
16.2.1 Company Profile
16.2.2 Main Business and Luxury Massage Chair Information
16.2.3 SWOT Analysis of Osaki
16.2.4 Osaki Luxury Massage Chair Sales, Revenue, Price and Gross Margin (2014-2019)
16.3 Inada
16.3.1 Company Profile
16.3.2 Main Business and Luxury Massage Chair Information
16.3.3 SWOT Analysis of Inada
16.3.4 Inada Luxury Massage Chair Sales, Revenue, Price and Gross Margin (2014-2019)
16.4 Human Touch
16.4.1 Company Profile
16.4.2 Main Business and Luxury Massage Chair Information
16.4.3 SWOT Analysis of Human Touch
16.4.4 Human Touch Luxury Massage Chair Sales, Revenue, Price and Gross Margin (2014-2019)
16.5 Fujiiryoki
16.5.1 Company Profile
16.5.2 Main Business and Luxury Massage Chair Information
16.5.3 SWOT Analysis of Fujiiryoki
16.5.4 Fujiiryoki Luxury Massage Chair Sales, Revenue, Price and Gross Margin (2014-2019)
16.6 Titan
16.6.1 Company Profile
16.6.2 Main Business and Luxury Massage Chair Information
16.6.3 SWOT Analysis of Titan
16.6.4 Titan Luxury Massage Chair Sales, Revenue, Price and Gross Margin (2014-2019)
16.7 Cozzia
16.7.1 Company Profile
16.7.2 Main Business and Luxury Massage Chair Information
16.7.3 SWOT Analysis of Cozzia
16.7.4 Cozzia Luxury Massage Chair Sales, Revenue, Price and Gross Margin (2014-2019)

Continued……

Contact Us: Sales@Wiseguyreports.Com Ph: +1-646-845-9349 (Us) Ph: +44 208 133 9349 (Uk)

NORAH TRENT
WISE GUY RESEARCH CONSULTANTS PVT LTD
646-845-9349 (US), +44 208 133 9349 (UK)
email us here
["facebook", "twitter", "linkedin"]
{"facebook"=>"", "twitter"=>"", "linkedin"=>""}


Source: EIN Presswire

Healthcare IT Services Market 2019 Industry Growth, Share, Trends, Demand, Analysis and Forecast to 2025

This report covers market characteristics, size and growth, segmentation, regional breakdowns, competitive landscape, market shares, trends and strategies

PUNE, INDIA, May 23, 2019 /EINPresswire.com/ — The report provides a comprehensive analysis of the Healthcare IT Services industry market by types, applications, players and regions. This report also displays the 2014-2025 production, Consumption, revenue, Gross margin, Cost, Gross, market share, CAGR, and Market influencing factors of the Healthcare IT Services industry in USA, EU, China, India, Japan and other regions

Market Analysis by Players: This report includes following top vendors in terms of company basic information, product category, sales (volume), revenue (Million USD), price and gross margin (%).
Mckesson
Allscript
GE Healthcare
Siemens Healthcare
Cerner
Becton Dickinson
Novartis
CGI
Global Healthcare Exchange (GHX)
Atos IT Services
Epic System
Egton Medical Information System (EMIS)

Request a Free Sample Report @ https://www.wiseguyreports.com/sample-request/4058977-2019-global-healthcare-it-services-industry-depth-research-report

Market Analysis by Regions: Each geographical region is analyzed as Sales, Market Share (%) by Types & Applications, Production, Consumption, Imports & Exports Analysis, and Consumption Forecast.
USA
Europe
Japan
China
India
Southeast Asia
South America
South Africa
Others

Market Analysis by Types: Each Type is studied as Sales and Market Share (%), Revenue (Million USD), Price, Gross Margin and more similar information.
Medical Imaging
Consulting & Outsourcing
Managed Services
Order & Inventory Management
Document Management

Market Analysis by Applications: Each application is studied as Sales and Market Share (%), Revenue (Million USD), Price, Gross Margin and more similar information.
Healthcare Analytics
Patient Care Management
Fraud Management

Table of Content

1 Healthcare IT Services Market Overview
1.1 Product Overview of Healthcare IT Services
1.2 Classification of Healthcare IT Services
1.2.1 Type 1
1.2.2 Type 2
1.2.3 Type 3
1.2.4 Type 4
1.3 Applications of Healthcare IT Services
1.3.1 Application 1
1.3.2 Application 2
1.3.3 Application 3
1.3.4 Application 4
1.4 Global Healthcare IT Services Market Regional Analysis
1.4.1 USA Market Present Situation Analysis
1.4.2 Europe Market Present Situation Analysis
1.4.3 Japan Market Present Situation Analysis
1.4.4 China Market Present Situation Analysis
1.4.5 India Market Present Situation Analysis
1.4.6 Southeast Asia Market Present Situation Analysis
1.4.7 South America Market Present Situation Analysis
1.4.8 South Africa Market Present Situation Analysis
1.5 Healthcare IT Services Industry Development Factors Analysis
1.5.1 Healthcare IT Services Industry Development Opportunities Analysis
1.5.2 Healthcare IT Services Industry Development Challenges Analysis
1.6 Healthcare IT Services Consumer Behavior Analysis

2 Global Healthcare IT Services Competitions by Players
2.1 Global Healthcare IT Services Sales (Volume) and Market Share (%) by Players
2.2 Global Healthcare IT Services Revenue (Million USD) and Share by Players (2017-2018)
2.3 Global Healthcare IT Services Price (USD/Volume) by Players (2017-2018)
2.4 Global Healthcare IT Services Gross Margin by Players (2017-2018)

3 Global Healthcare IT Services Competitions by Types
3.1 Global Healthcare IT Services Sales (Volume) and Market Share (%) by Types
3.2 Global Healthcare IT Services Revenue (Million USD) and Share by Type (2014-2019)
3.3 Global Healthcare IT Services Price (USD/Volume) by Type (2014-2019)
3.4 Global Healthcare IT Services Gross Margin by Type (2014-2019)
3.5 USA Healthcare IT Services Sales (Volume) and Market Share (%) by Type
3.6 China Healthcare IT Services Sales (Volume) and Market Share (%) by Type
3.7 Europe Healthcare IT Services Sales (Volume) and Market Share (%) by Type
3.8 Japan Healthcare IT Services Sales (Volume) and Market Share (%) by Type
3.9 India Healthcare IT Services Sales (Volume) and Market Share (%) by Type
3.10 Southeast Asia Healthcare IT Services Sales (Volume) and Market Share (%) by Type
3.11 South America Healthcare IT Services Sales (Volume) and Market Share (%) by Type
3.12 South Africa Healthcare IT Services Sales (Volume) and Market Share (%) by Type

4 Global Healthcare IT Services Competitions by Applications
4.1 Global Healthcare IT Services Sales (Volume) and Market Share (%) by Applications
4.2 Global Healthcare IT Services Revenue (Million USD) and Share by Applications (2014-2019)
4.3 Global Healthcare IT Services Price (USD/Volume) by Applications (2014-2019)
4.4 Global Healthcare IT Services Gross Margin by Applications (2014-2019)
4.5 USA Healthcare IT Services Sales (Volume) and Market Share (%) by Applications
4.6 China Healthcare IT Services Sales (Volume) and Market Share (%) by Applications
4.7 Europe Healthcare IT Services Sales (Volume) and Market Share (%) by Applications
4.8 Japan Healthcare IT Services Sales (Volume) and Market Share (%) by Applications
4.9 India Healthcare IT Services Sales (Volume) and Market Share (%) by Applications
4.10 Southeast Asia Healthcare IT Services Sales (Volume) and Market Share (%) by Applications
4.11 South America Healthcare IT Services Sales (Volume) and Market Share (%) by Applications
4.12 South Africa Healthcare IT Services Sales (Volume) and Market Share (%) by Applications

5 Global Healthcare IT Services Production Market Analysis by Regions
5.1 Global Healthcare IT Services Production (Volume) and Market Share (%) by Regions
5.1.1 USA Healthcare IT Services Market Production Present Situation Analysis
5.1.2 Europe Healthcare IT Services Market Production Present Situation Analysis
5.1.3 China Healthcare IT Services Market Production Present Situation Analysis
5.1.4 Japan Healthcare IT Services Market Production Present Situation Analysis
5.1.5 India Healthcare IT Services Market Production Present Situation Analysis
5.1.6 Southeast Asia Healthcare IT Services Market Production Present Situation Analysis
5.1.7 South America Healthcare IT Services Market Production Present Situation Analysis
5.1.8 South Africa Healthcare IT Services Market Production Present Situation Analysis
5.2 Global Healthcare IT Services Production Value (Million USD) and Share by Region (2014-2019)
5.3 Global Healthcare IT Services Price (USD/Volume) by Region (2014-2019)
5.4 Global Healthcare IT Services Gross Margin by Region (2014-2019)

……Continued

Access Complete Report @ https://www.wiseguyreports.com/reports/4058977-2019-global-healthcare-it-services-industry-depth-research-report

NORAH TRENT
Wise Guy Reports
841 198 5042
email us here
["facebook", "twitter", "linkedin"]
{"facebook"=>"", "twitter"=>"", "linkedin"=>""}


Source: EIN Presswire

grit42 software supports the global fight against superbugs

As part of Evotec’s AMR efforts, the bacteriology & omics team in Lyon has selected grit42’s software platform.

COPENHAGEN, DENMARK, May 23, 2019 /EINPresswire.com/ — Copenhagen, Denmark — May 23, 2019 — Evotec is a globally operating drug discovery and development partnership company whose focus areas include infectious diseases. In this area Evotec works on a large portfolio of projects pertaining to antimicrobial resistance (AMR), superbug infections, tuberculosis and malaria, as well as novel antiviral therapies. As part of Evotec’s AMR efforts, the bacteriology & omics team in Lyon has selected grit42’s software platform, specifically the Growth Curves app.

In the fight against superbugs, characterizing bacterial growth in various environments is critical. Biolog's high-throughput phenotypic microarray instrument, OmniLog, allows the identification of phenotypes of mutants and the fingerprinting compound activity by monitoring growth in hundreds of different conditions. The Growth Curves app from grit42, offers a nice and interactive way to analyse the data from the OmniLog instrument. For example, it shows the average of replicates and in the plate format, it displays the percentage of inhibition with the ability to switch reference in one click. On top of these – and additional – features, the system significantly accelerates the analysis workflow.

The Growth Curves app from grit42 has been developed together with the bacterial infections group at a top 10 pharma and input from US governmental institutions. An early version was shown by a scientist from Sanofi in June of 2017 at the AMR focused ‘IMI ND4BB Translocation’ workshop held at Helmholtz HZI, Germany, and since then the time has been spent perfecting the app. The old workflow involves more than eight hours of analysis work, after the experiment is done, compared to grit42’s redesigned workflow of around half an hour in total.

“At the AMR Conference in Berlin in March of 2019, both WHO, the Pew Trust, and the BEAM Alliance stressed that there are not enough antibiotics in development to meet patient needs. The current state of AMR research was best phrased by Professor Kevin Outterson from Boston University and CARB X, who said: We’re on a boat. The boat is in a storm. And it’s on fire!” comments CEO and co-founder of grit42, Claus Stie Kallesøe, and continues, “We’re proud to be one of the few Danish companies in global fight against superbugs and thrilled that one of the leading drug discovery alliance companies in the world, has selected our software for their AMR research. It fits perfectly with the AMR work we’ve done with the Innovative Medicines Initiative (IMI) in Europe and hope to continue in the future as well.”

The app works as a standalone tool, ready to run from grit42’s servers with a personal login. Other than the described workflow, the Growth Curves app also supports these types of studies: Profiling of cleanroom bacteria – identification of unknown microbes or fungi, optimization of cell lines and culture conditions in bioprocess development, characterization of cell phenotypes for taxonomic or epidemiological studies, determination of a cell's metabolic and chemical sensitivity properties, as well as mode of action studies of antibiotics. For more information, please visit: http://grit42.com/growthcurves/

ABOUT EVOTEC SE
Evotec is a drug discovery alliance and development partnership company focused on rapidly progressing innovative product approaches with leading pharmaceutical and biotechnology companies, academics, patient advocacy groups and venture capitalists. We operate worldwide and our more than 2,600 employees provide the highest quality stand-alone and integrated drug discovery and development solutions. We cover all activities from target-to-clinic to meet the industry’s need for innovation and efficiency in drug discovery and development (EVT Execute). The Company has established a unique position by assembling top-class scientific experts and integrating state-of-the-art technologies as well as substantial experience and expertise in key therapeutic areas including neuronal diseases, diabetes and complications of diabetes, pain and inflammation, oncology, infectious diseases, respiratory diseases and fibrosis. On this basis, Evotec has built a broad and deep pipeline of approx. 100 co-owned product opportunities at clinical, pre-clinical and discovery stages (EVT Innovate). Evotec has established multiple long-term alliances with partners including Bayer, Boehringer Ingelheim, Celgene, CHDI, Novartis, Novo Nordisk, Pfizer, Sanofi, Takeda, UCB and others. For additional information, please go to www.evotec.com and follow us on Twitter @Evotec.

Lasse Goerlitz
grit42
+45 2758 2601
email us here
Visit us on social media:
Twitter


Source: EIN Presswire

Dental Implants in Center Valley are Available from Castle Dental

Logo for Center Valley dentist

Center Valley dentists at Castle Dental providing dental crowns.

Dental implants are available from Center Valley dentists at Castle Dental.

CENTER VALLEY, PENNSYLVANIA, UNITED STATES, May 23, 2019 /EINPresswire.com/ — Center Valley dentists at Castle Dental offer dental implants, one of the most popular missing tooth solutions available.

Dental implants are used to replace a missing tooth by attaching to the jaw bone. They are stable, durable, and natural looking. They also improve oral health by helping the jawbone recover from deterioration caused by tooth loss.

“We have helped hundreds of patients find a fuller, more confident smile with dental implants,” says Dr. Matthew Lang.

Castle Dental has invested in the latest technology, including the Galileos 3D Dental Conebeam, which scans the mouth, face, and jaw. Supplemental treatments like bone grafts and sinus lifts are available to help improve the implant success rate.

Not everyone may be a candidate for dental implants. Patients are encouraged to schedule a consultation with Dr. Lang.

To learn more about dental implants and other cosmetic dentistry services in Center Valley, schedule an appointment by visiting http://castledentalcare.com/appointment-request/. New patients are currently being accepted.

About Castle Dental: Castle Dental is a leading provider of cosmetic dentistry and dental implants in Center Valley, PA. Doctors Matthew Lang and Lucas Mantilla offer patients high-quality, experienced, and comfortable care. Sedation dentistry, dental crowns, and general dentistry are also available. To learn more visit https://www.castledentalcare.com.

Melissa Dugan
Castle Dental
+1 6102822249
email us here
Visit us on social media:
Facebook


Source: EIN Presswire

Surgical Navigation Software Market 2019 Global Analysis, Opportunities and Forecast to 2025

This report covers market characteristics, size and growth, segmentation, regional breakdowns, competitive landscape, market shares, trends and strategies

PUNE, INDIA, May 23, 2019 /EINPresswire.com/ — The report provides a comprehensive analysis of the Surgical Navigation Software industry market by types, applications, players and regions. This report also displays the 2014-2025 production, Consumption, revenue, Gross margin, Cost, Gross, market share, CAGR, and Market influencing factors of the Surgical Navigation Software industry in USA, EU, China, India, Japan and other regions

Market Analysis by Players: This report includes following top vendors in terms of company basic information, product category, sales (volume), revenue (Million USD), price and gross margin (%).
Medtronic
Stryker
Brainlab
GE Healthcare
B. Braun Melsungen
Johnson & Johnson
Zimmer Biomet
ClaroNav
Karl Storz
Siemens Healthineers
Scopis GmbH
Fiagon AG
Surgical Theater
XiON Medical

Request a Free Sample Report @ https://www.wiseguyreports.com/sample-request/4059060-2019-global-surgical-navigation-software-industry-depth-research-report

Market Analysis by Regions: Each geographical region is analyzed as Sales, Market Share (%) by Types & Applications, Production, Consumption, Imports & Exports Analysis, and Consumption Forecast.
USA
Europe
Japan
China
India
Southeast Asia
South America
South Africa
Others

Market Analysis by Types: Each Type is studied as Sales and Market Share (%), Revenue (Million USD), Price, Gross Margin and more similar information.
Optical
Electromagnetic (EM)
Hybrid

Market Analysis by Applications: Each application is studied as Sales and Market Share (%), Revenue (Million USD), Price, Gross Margin and more similar information.
Orthopedic
Neurosurgery
ENT
Other

Table of Content

1 Surgical Navigation Software Market Overview
1.1 Product Overview of Surgical Navigation Software
1.2 Classification of Surgical Navigation Software
1.2.1 Type 1
1.2.2 Type 2
1.2.3 Type 3
1.2.4 Type 4
1.3 Applications of Surgical Navigation Software
1.3.1 Application 1
1.3.2 Application 2
1.3.3 Application 3
1.3.4 Application 4
1.4 Global Surgical Navigation Software Market Regional Analysis
1.4.1 USA Market Present Situation Analysis
1.4.2 Europe Market Present Situation Analysis
1.4.3 Japan Market Present Situation Analysis
1.4.4 China Market Present Situation Analysis
1.4.5 India Market Present Situation Analysis
1.4.6 Southeast Asia Market Present Situation Analysis
1.4.7 South America Market Present Situation Analysis
1.4.8 South Africa Market Present Situation Analysis
1.5 Surgical Navigation Software Industry Development Factors Analysis
1.5.1 Surgical Navigation Software Industry Development Opportunities Analysis
1.5.2 Surgical Navigation Software Industry Development Challenges Analysis
1.6 Surgical Navigation Software Consumer Behavior Analysis

2 Global Surgical Navigation Software Competitions by Players
2.1 Global Surgical Navigation Software Sales (Volume) and Market Share (%) by Players
2.2 Global Surgical Navigation Software Revenue (Million USD) and Share by Players (2017-2018)
2.3 Global Surgical Navigation Software Price (USD/Volume) by Players (2017-2018)
2.4 Global Surgical Navigation Software Gross Margin by Players (2017-2018)

3 Global Surgical Navigation Software Competitions by Types
3.1 Global Surgical Navigation Software Sales (Volume) and Market Share (%) by Types
3.2 Global Surgical Navigation Software Revenue (Million USD) and Share by Type (2014-2019)
3.3 Global Surgical Navigation Software Price (USD/Volume) by Type (2014-2019)
3.4 Global Surgical Navigation Software Gross Margin by Type (2014-2019)
3.5 USA Surgical Navigation Software Sales (Volume) and Market Share (%) by Type
3.6 China Surgical Navigation Software Sales (Volume) and Market Share (%) by Type
3.7 Europe Surgical Navigation Software Sales (Volume) and Market Share (%) by Type
3.8 Japan Surgical Navigation Software Sales (Volume) and Market Share (%) by Type
3.9 India Surgical Navigation Software Sales (Volume) and Market Share (%) by Type
3.10 Southeast Asia Surgical Navigation Software Sales (Volume) and Market Share (%) by Type
3.11 South America Surgical Navigation Software Sales (Volume) and Market Share (%) by Type
3.12 South Africa Surgical Navigation Software Sales (Volume) and Market Share (%) by Type

4 Global Surgical Navigation Software Competitions by Applications
4.1 Global Surgical Navigation Software Sales (Volume) and Market Share (%) by Applications
4.2 Global Surgical Navigation Software Revenue (Million USD) and Share by Applications (2014-2019)
4.3 Global Surgical Navigation Software Price (USD/Volume) by Applications (2014-2019)
4.4 Global Surgical Navigation Software Gross Margin by Applications (2014-2019)
4.5 USA Surgical Navigation Software Sales (Volume) and Market Share (%) by Applications
4.6 China Surgical Navigation Software Sales (Volume) and Market Share (%) by Applications
4.7 Europe Surgical Navigation Software Sales (Volume) and Market Share (%) by Applications
4.8 Japan Surgical Navigation Software Sales (Volume) and Market Share (%) by Applications
4.9 India Surgical Navigation Software Sales (Volume) and Market Share (%) by Applications
4.10 Southeast Asia Surgical Navigation Software Sales (Volume) and Market Share (%) by Applications
4.11 South America Surgical Navigation Software Sales (Volume) and Market Share (%) by Applications
4.12 South Africa Surgical Navigation Software Sales (Volume) and Market Share (%) by Applications

5 Global Surgical Navigation Software Production Market Analysis by Regions
5.1 Global Surgical Navigation Software Production (Volume) and Market Share (%) by Regions
5.1.1 USA Surgical Navigation Software Market Production Present Situation Analysis
5.1.2 Europe Surgical Navigation Software Market Production Present Situation Analysis
5.1.3 China Surgical Navigation Software Market Production Present Situation Analysis
5.1.4 Japan Surgical Navigation Software Market Production Present Situation Analysis
5.1.5 India Surgical Navigation Software Market Production Present Situation Analysis
5.1.6 Southeast Asia Surgical Navigation Software Market Production Present Situation Analysis
5.1.7 South America Surgical Navigation Software Market Production Present Situation Analysis
5.1.8 South Africa Surgical Navigation Software Market Production Present Situation Analysis
5.2 Global Surgical Navigation Software Production Value (Million USD) and Share by Region (2014-2019)
5.3 Global Surgical Navigation Software Price (USD/Volume) by Region (2014-2019)
5.4 Global Surgical Navigation Software Gross Margin by Region (2014-2019)

6 Global Surgical Navigation Software Sales Market Analysis by Region
6.1 USA Surgical Navigation Software Market Consumption Present Situation Analysis
6.2 Europe Surgical Navigation Software Market Consumption Present Situation Analysis
6.3 China Surgical Navigation Software Market Consumption Present Situation Analysis
6.4 Japan Surgical Navigation Software Market Consumption Present Situation Analysis
6.5 India Surgical Navigation Software Market Consumption Present Situation Analysis
6.6 Southeast Asia Surgical Navigation Software Market Consumption Present Situation Analysis
6.7 South America Surgical Navigation Software Market Consumption Present Situation Analysis
6.8 South Africa Surgical Navigation Software Market Consumption Present Situation Analysis

……Continued

Access Complete Report @ https://www.wiseguyreports.com/reports/4059060-2019-global-surgical-navigation-software-industry-depth-research-report

NORAH TRENT
Wise Guy Reports
841 198 5042
email us here
["facebook", "twitter", "linkedin"]
{"facebook"=>"", "twitter"=>"", "linkedin"=>""}


Source: EIN Presswire

Global Sports Medicine Market 2019 Analysis, Consumption, Segmentation, Trend, Growth, Opportunities & Forecast To 2022

“Sports Medicine – Market Demand, Growth, Opportunities, Manufacturers and Analysis of Top Key Players to 2022”

PUNE, MAHARASHTRA, INDIA, May 23, 2019 /EINPresswire.com/ — Sports Medicine Market by Product Type (Body Reconstruction Products, Body Support & Recovery and Accessories) and by Application like Shoulder Injuries, Ankle & Foot Injuries, Elbow & Wrist Injuries, Back & Spine Injuries, Hip & Groin Injuries, Knee Injuries and Other Injuries – Global Industry Perspective, Comprehensive Analysis and Forecast, 2019 – 2022

Wiseguyreports.Com Adds “Sports Medicine – Market Demand, Growth, Opportunities, Manufacturers and Analysis of Top Key Players to 2022” To Its Research Database

The report covers forecast and analysis for the Sports Medicine market on a global and regional level. The study provides historical data from 2014 along with a forecast from 2018 to 2022 based on revenue (USD Million). The study includes drivers and restraints for the Sports Medicine market along with the impact they have on the demand over the forecast period. Additionally, the report includes the study of opportunities available in the Sports Medicine market on a global level. 
This report offers comprehensive coverage of global Sports Medicine market along with, market trends, drivers, and restraints of Sports Medicine market. This report includes a detailed competitive scenario and product portfolio of key vendors. To understand the competitive landscape in the market, an analysis of Porters five forces model for the Sports Medicine market has also been included. The study encompasses a market attractiveness analysis, wherein all segments are benchmarked based on their market size, growth rate, and general attractiveness. This report is prepared by using data sourced from in-house databases, secondary and primary research team of industry experts. Research analysts and consultants cooperate with leading companies of the concerned domain to verify every value of data exists in this report.  

 Get Free Sample Report of Sports Medicine Market@ https://www.wiseguyreports.com/sample-request/3797327-sports-medicine-market-by-product-type-body-reconstruction            

The study provides a decisive view on the Sports Medicine market by segmenting the market based on product type, application, and regions. All these segments have been analyzed based on present and future trends and the market is estimated from 2018 to 2022. The product type market covered under this study includes Body Reconstruction Products, Body Support Recovery and Accessories. The Application covered in this study includes Shoulder Injuries, Ankle Foot Injuries, Elbow Wrist Injuries, Back Spine Injuries, Hip Groin Injuries, Knee Injuries and Other Injuries. This report also includes the current and forecast demand for the region of North America, Europe, Asia Pacific and Latin America. Key operating players for Sports Medicine market are 
This report segments the Sports Medicine market as follows: 
Global Sports Medicine Market: By Product Type Segment Analysis  Body Reconstruction Products  Implants  Fracture and Ligament Repair Devices  Arthroscopy Devices  Prosthetic Devices  Orthobiologics  Body Support Recovery  Braces and Support  Compression Clothing  Physiotherapy  Thermal Therapy  Electrostimulation  Other Therapies*  Accessories 
Global Sports Medicine Market: By Application Segment Analysis  Shoulder Injuries  Ankle Foot Injuries  Elbow Wrist Injuries  Back Spine Injuries  Hip Groin Injuries  Knee Injuries  Other Injuries 
Global Sports Medicine Market: By Regional Segment Analysis  North America  The U.S.  Europe  UK  France  Germany  Asia Pacific  China  Japan  India  Latin America  Brazil  Middle East and Africa

 Complete report with Comprehensive table of contents@ https://www.wiseguyreports.com/reports/3797327-sports-medicine-market-by-product-type-body-reconstruction  

Major Key Points in Table of Content

Chapter 1. Introduction

Chapter 2. Executive Summary 

Chapter 3. Medical device reprocessing market Market Dynamics 

Chapter 4. Global Medical device reprocessing market Competitive Landscape 

Chapter 5. Global Medical device reprocessing market Device type Analysis 

Chapter 6. Global Medical device reprocessing market End User Analysis 

Chapter 7. Global Medical device reprocessing market Regional Segment Analysis 

Chapter 8. Company Profile 

 Continued…………………….

Also Read:

 

NORAH TRENT
WISE GUY RESEARCH CONSULTANTS PVT LTD
646-845-9349 (US), +44 208 133 9349 (UK)
email us here
["facebook", "twitter", "linkedin"]
{"facebook"=>"", "twitter"=>"", "linkedin"=>""}


Source: EIN Presswire

Dr. Scott P. Zack Reveals Surprising Conditions Treatable with Chiropractics

Oakland County chiropractor Dr. Scott P. Zack reveals three common conditions little-known to be treatable with chiropractic care.

BLOOMFIELD HILLS, MICHIGAN, USA, May 22, 2019 /EINPresswire.com/ — From inner-ear issues to carpal tunnel syndrome, chiropractic care is today widely used to treat a number of conditions not directly tied to neck and back pain, traditionally the most common reasons for seeking the help of a chiropractor. That's according to Detroit metropolitan area of Michigan chiropractor Dr. Scott P. Zack as he explores three common health complaints which can be addressed using chiropractic medicine.

"It's a little-known fact that chiropractic care, in addition to dealing with neck and back pain, may also be used to effectively treat conditions bound to the wider musculoskeletal and nervous systems," reveals Dr. Scott P. Zack, "both of which are closely tied to countless other conditions, as well as more general health and wellness."

With chiropractic care, he says, it's possible to treat many of the most important bones and joints in the body, including those in the legs, arms, ears, and jaw. "The jaw and ears, in particular, are notorious for being the root of a huge number of highly painful or debilitating conditions," Dr. Zack goes on to explain, "many of which may be addressed with the help of an experienced chiropractor."

Of three specific conditions highlighted by the expert, Dr. Zack first turns to carpal tunnel syndrome. "Most often caused by a compressed nerve in the wrist, carpal tunnel syndrome causes tingling and numbness of the hands and fingers," he explains, "which is highly troublesome for many patients."

Traditional treatments for carpal tunnel syndrome include steroids and anti-inflammatory drugs, and, in some cases, surgery.

Yet, says Dr. Zack, chiropractic care can, instead, be utilized to treat the condition by performing chiropractic adjustments of the wrist or wrists. "By ever-so-slightly manipulating the lunate, one of the bones in the wrist, symptoms of carpal tunnel syndrome can be addressed by a chiropractor without the need for expensive drugs or surgery," he adds.

Next, Dr. Zack points toward what's known as benign paroxysmal positional vertigo. "Responsible for dizziness and vertigo-like symptoms, benign paroxysmal positional vertigo is often the result of debris in the ear canals," the expert explains, "something which chiropractic repositioning maneuvers can be used to address, shifting the debris and relieving the often highly debilitating symptoms of the condition."

Lastly, Dr. Scott P. Zack touches on other, more general inner-ear issues. "Chiropractic techniques may be used to successfully treat the painful symptoms of ear infections, for example, as well as other illnesses and conditions tied to this part of the body," he reveals.

By promoting the drainage of any trapped fluid, itself a common cause of ear infections, chiropractic medicine can be used both to treat and to relieve the symptoms of numerous conditions of the ears.

"Manipulation of the tiny bones within the ear is also an option," Dr. Scott P. Zack adds, wrapping up, "with misalignment of these bones capable of causing or contributing toward a wide range of ear-related issues, and thus representing something else which can, perhaps surprisingly, be treated by an experienced chiropractor."

Caroline Hunter
Web Presence, LLC
+1 786-551-9491
email us here


Source: EIN Presswire

At M2Moms® Every Day Is Mother’s Day

Marketers gather to build business with today’s moms

M2Moms® helps marketers build business with today’s moms. It features new research, social, digital, & mobile sessions, influencer & shopper marketing case studies, & how-to presentations.”

— Nan McCann, M2Moms® Producer

NEW YORK, NY, USA, May 22, 2019 /EINPresswire.com/ — “Moms continually evolve as they face new life stages, new time demands and new choices. At M2Moms® – The Marketing to Moms Conference every day is mother’s day as we focus on helping marketers achieve better business results with today’s ever-changing moms,” according to Nan McCann, M2Moms® producer. Now in its 15th year, the conference is presented by The Center for Positive Marketing at Fordham University. It features premier moms research, and social, digital, and mobile sessions, influencer and shopper marketing case studies, and how-to presentations to show marketing execs what works, where, when & why with moms. M2Moms® will be held October 16 & 17, 2019, NYC.

2019 Highlights, China, Mom Tech, & Gen Z:
“We’re thrilled this year that Skyler Mattson, President of WongDoody & The Motherboard has agreed to be our guest emcee,” McCann said. “Skyler is one of the most important and successful voices in marketing to moms and has led her agency to numerous industry awards and accolades including Ad Age’s Agency of the Year in 2018. She is passionate about helping brands create authentic and effective marketing to moms campaigns. Skyler will introduce two equally compelling keynotes. First, one of the world’s leading experts on female consumers, Bridget Brennan, CEO of The Female Factor, who will share insights from her latest best seller: Winning Her Business: How to Transform the Customer Experience for the World’s Most Powerful Consumers. And last year’s M2Moms® best speaker award winner, Australia’s Katerina McCarter, Founder/CEO of Marketing to Mums who will present highlights from her new book The Mother of All Opportunities.”

“This year’s new sessions & topics include a look at the moms marketing in China. It absolutely dwarfs the US market. Every year 17 million new babies are born in China versus only 4 million new US babies. We’ll be especially focusing on tech with segments on how she's using every screen at her disposal to network, search, get advice, recommend, shop & buy. The tech sessions & discussions will be presented by Google, Facebook, YouTube, Foursquare, JetBlack & Instagram. Additionally, we’ll study how “smart” innovation is changing the home environment. Plus, we’ll examine how inter-generational marketing has become a key component of marketing to moms. But, probably our most timely new presentations will look at the very real differences between millennial moms and the massive emerging cohort of Gen Z moms.”

Creative Engagement & Awards:
“It’s not all work, to stimulate everyone’s creative juices we’re introducing our first ever female targeted startup “Shark Tank” featuring quick elevator pitches with a cash prize to the winner voted by the M2Moms® audience. Plus, in keeping with our annual traditions we’ll present our “Mom First” & “This Woman Means Business” Awards. The “Mom First” Award is given to a mom who saw and successfully pursued a business opportunity she discovered while being a mom. The “This Women Means Business” Award is presented to a proven business leader… an innovator and visionary…who in words and actions recognizes that women can be a transforming economic force in the world today…that for every successful enterprise women mean business.”

M2Moms® Sponsors:
Presenting Sponsor for 2019 is The Center for Positive Marketing. Additional sponsors include: Google, Facebook, Foursquare, WongDoody, The MotherBoard, FlashLight Insights, Marketing to Mums, The Female Factor, Snippies and Tiny Tutus.

About M2Moms®:
M2Moms® -The Marketing to Moms Conference
October 16 & 17, 2019
Pope Auditorium at Fordham Univ.
113 W. 60TH St., NYC

For information: www.M2Moms.com or 860.724.2649 or nan@pme-events.com
25% Early Registration Discount Code Is EB25 at: https://www.m2moms.com/registration/

M2Moms® is produced by PME® Enterprises LLC, a sales and marketing company specializing in event creation, promotion, production and management.

Nanci McCann
PME Enterprises LLC
+1 860-724-2649
email us here


Source: EIN Presswire

Rosemary Barclay of Old Lyme, CT Recommends Minimizing Artificial Food Color Consumption for Children

Rosemary Barclay

OLD LYME, CONNECTICUT, USA, May 22, 2019 /EINPresswire.com/ — Dyes have recently been linked to issues with hyperactivity and ADHD. Rosemary Barclay of Old Lyme, CT recommends minimizing your child’s consumption of potentially harmful dyes, preservatives and additives in foods

The effects of artificial food coloring on behavior in children has been studied for more than 40 years. After reviewing recently published research, Rosemary Barclay, owner and founder of Bonne Santé Wellness Center in Old Lyme, CT, shares her findings on the harmful effects of artificial food coloring on child behavior. These commonly used ingredients are often times not given a second thought by parents, but can have a significant long term negative impact on children with ADHD and hyperactivity. Rosemary Barclay shares her thoughts on the effects of food colorings, dyes and additives and their effects on developing children.

Artificial dyes are added to foods to enhance or maintain their appearance. This could mean brightening existing colors, prevent the loss of colors through elements of transportation and the environment, creating enticing looking beverages, or preserving a products appearance throughout its shelf life. The Food and Drug Administration currently deems nine different artificial colors to be safe but recent concerns have arisen over the use of food colorings and dyes in foods. In 2007, a study conducted in the UK linked the preservative sodium benzoate increased hyperreactivity in children and the European Union required labelling stating that this preservative “may produce an effect on activity and attention in children”.

Two types of artificial food coloring are used, dyes and lakes. Dyes are water-soluble; often found in liquids, granules, or powders. Lakes are not water-soluble; they are found in food products containing fats and oils. Food dye is found in beverages more than any other product, as people often associate a color with a particular flavor. A brightly colored drink can be more appealing and look tastier. Rosemary Barclay urges the general public to stay away from drinks with heavy use of food coloring often found in sodas, sports drinks, and cocktail mixers. These should not be given to children on a daily basis.

Sweets are another hidden source of food coloring, so it might be best to limit that Halloween candy. Rosemary Barclay notes that they can also be found in more unsuspecting sweet sources like cereals, fruit snacks, ice cream, popsicles, icings and even toaster tarts. Try choosing natural breakfast and snack choices like fruit, yogurt, and cottage cheese. Parents should opt for foods that are colored with natural herbs and spices like paprika, tumeric and annatto.

Rosemary Barclay of Old Lyme, CT suggests examining your child’s daily food intake and determine where artificial food coloring can be minimized. Also, research foods that your children like to eat and make substitutions for those foods that contain less food coloring. An example includes swapping GoGurt out for plain yogurt with toppings like honey, smashed fruit, or granola. Completely eliminating artificial food coloring is not an impossible task, buteven minimizing consumption can make a huge difference.

Clearly further research needs to be performed on individual food dyes, preservatives and colorings on the developing brain.To date scientists, consumers and the government have not found conclusive evidence linking dyes to hyperreactivity in children but not enough research has been conducted.

Rosemary Barclay states: “Artificial food coloring needs more research for a definitive conclusion on the effects it has on child development and behavior. However, although limited studies have been done, we have a pretty good idea that artificial food dyes are not nutrients and are not healthy for children and food manufacturers should be required to conduct studies showing safety ”. “These dyes and preservatives may affect a subgroup of children but isn’t the healthier choice just to avoid them altogether?”

About Rosemary Barclay

Rosemary Barclay of Old Lyme, CT believes that nutrition is fundamental to good health, and affects many faucets of well-being including the skin, energy, immunity, mood, and performance. The Bonne Santé Wellness Center in Old Lyme, CT, offers solutions to problematic skin without the use of antibiotics or harsh chemicals.
She earned a bachelor’s degree and a PhD in biochemistry in addition to becoming a board certified nutrition specialist, certified esthetician, and acne specialist. Rosemary Barclay lives in Old Lyme, CT.

Caroline Hunter
Web Presence, LLC
+1 7865519491
email us here


Source: EIN Presswire